Oncolytic Biotechnology

Oncolytic Biotechnology is the investigation of oncolytic infection, the infection that specially taints and slaughters malignant growth cells. As the tainted malignancy cells are obliterated by oncolysis, they discharge new irresistible infection particles or virions to help demolish the rest of the tumor. Oncolytic infections are thought not exclusively to cause direct annihilation of the tumor cells, yet in addition to animate host against tumor safe reactions.

  • Tumorigenic infections
  • Oncolysis
  • Stimulation of host anti-tumor immune response

Related Conference of Oncolytic Biotechnology

August 22-23, 2019

5th International Congress on Epigenetics & Chromatin

Vienna, Austria
August 30-31, 2019

International Conference on Genetic Disorders

Bangkok, Thailand
September 13-14, 2019

12th World Congress on Cell & Tissue Science

October 21-22, 2019

23rd European Biotechnology Congress

Zurich, Switzerland
November 26-27, 2019

International Conference On Genomics and Molecular Biology

Lisbon | Portugal
November 26-27, 2019

International Conference on Cell and Gene Therapy

| Lisbon, Portugal
February 24-25, 2020

24th Global Congress on Biotechnology

London, UK
March 16-17, 2020 |

12th World Congress and Expo on Cell & Stem Cell Research

Chicago, Illinois, USA
May 21-22, 2020

24th European Biotechnology Congress


Oncolytic Biotechnology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in